» Authors » Azhar Al-Khulaifi

Azhar Al-Khulaifi

Explore the profile of Azhar Al-Khulaifi including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 5
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Khulaifi A, Khatib M, Sayed G, Doi S, Danjuma M
J Reprod Immunol . 2024 Sep; 166:104320. PMID: 39288674
Background: Aspirin is frequently used in pregnancy to decrease the risk of developing pre-eclampsia. Studies have highlighted this potential benefit which in theory happens by inhibition of platelet function. However,...
2.
Darwish T, Al-Khulaifi A, Ali M, Mowafy R, Arredouani A, Doi S, et al.
PLoS One . 2024 Feb; 19(2):e0299166. PMID: 38354208
[This corrects the article DOI: 10.1371/journal.pone.0272091.].
3.
Abdulmajeed J, Khatib M, Dulli M, Sioufi S, Al-Khulaifi A, Stone J, et al.
Cancer Epidemiol . 2023 Dec; 88:102521. PMID: 38160570
Background: In oncology clinical trials, there is the assumption that randomization sufficiently balances confounding covariates and therefore average treatment effects are usually reported. This paper explores the wider benefits provided...
4.
Al-Khulaifi A, Khatib M, Ali E, Ali M, Danjuma M
Clin Ther . 2023 Sep; 45(11):e217-e221. PMID: 37722957
Purpose: Polypharmacy presents an increasing therapeutic challenge for physicians managing patients with chronic kidney disease (CKD). However, there is a lack of consensus regarding the specific medication count threshold that...
5.
Naseralallah L, Khatib M, Al-Khulaifi A, Danjuma M
Front Pharmacol . 2023 Feb; 14:1122898. PMID: 36843919
Polypharmacy and chronic kidney disease (CKD) are becoming increasingly common due to an ageing population and the rise of multimorbidity. In line with the therapeutic guidelines, managing CKD and its...
6.
7.
Darwish T, Al-Khulaifi A, Ali M, Mowafy R, Arredouani A, Doi S, et al.
PLoS One . 2022 Aug; 17(8):e0272091. PMID: 35944004
Introduction: Cystic fibrosis (CF) is a hereditary autosomal recessive disorder caused by a range of mutations in the CF Transmembrane Conductance Regulator (CFTR) gene. This gene encodes the CFTR protein,...